| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3B | $5.4B | $5.4B | $5.4B | $5.5B | $4.6B | $1.5B | $1.5B |
| Cost of Revenue | $2.7B | $2.6B | $2.9B | $3.0B | $2.8B | $2.3B | $0.8B | $2.7B |
| Gross Profit | $2.6B | $2.7B | $2.6B | $2.5B | $2.6B | $2.2B | $0.7B | $0.7B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.5B | $0.7B | $0.6B | $0.7B | $0.7B | $0.4B | $0.1B | $0.1B |
| Net Income | $0.4B | $0.5B | $0.2B | $0.4B | $0.9B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $1.25 | $1.59 | $0.61 | $1.11 | $2.58 | $0.36 | $0.00 | $0.04 |
| EPS (Diluted) | $1.24 | $1.58 | $0.60 | $1.10 | $2.53 | $0.36 | $0.00 | $0.04 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.6B | $6.5B | $6.4B | $6.2B | $6.4B | $5.5B | $5.3B | $5.2B |
| Current Assets | $3.1B | $3.1B | $3.1B | $2.7B | $2.9B | $2.5B | $2.2B | $2.4B |
| Cash & Equivalents | $1.2B | $1.4B | $1.3B | $0.8B | $0.7B | $0.8B | $0.6B | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.5B | $1.3B | $1.3B | $1.2B | $1.6B | $1.4B | $1.3B | $1.3B |
| Stockholders' Equity | $2.2B | $2.3B | $2.1B | $2.1B | $1.6B | $0.6B | $0.5B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.8B | $0.9B | $0.4B | $0.5B | $0.3B | $0.2B | $-0.0B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | $0.1B |
| Financing Cash Flow | $-0.6B | $-0.4B | $-0.2B | $-0.3B | $-0.4B | $-0.0B | $-0.0B | $-0.3B |